Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
2.7. Comparative Assay of the oxCNT-HA-CPT Nanovector vs. CPT Chemotherapy
Ask a
question
Favorite
To determine the efficacy of the nanovector, the previously described MTT assay was used in the cells exposed to treatments with oxCNT–HA–CPT and CPT for 24 h. Also, the nuclei contrast assay with DAPI was performed in these same cells.
Copyright and License information: ©2021 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
